Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conlin P O'Neil

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Biomaterials|December 25, 2010
Engineering complement activation on polypropylene sulfide vaccine nanoparticlesSusan N Thomas, André J van der Vlies, Conlin P O'Neil, et al.
Angewandte Chemie (International Ed. in English)|September 16, 2008
Superparamagnetic nanoparticles as a powerful systems biology characterization tool in the physiological contextJatuporn Salaklang, Benedikt Steitz, Andrija Finka, et al.
Nature Biotechnology|September 18, 2007
Exploiting lymphatic transport and complement activation in nanoparticle vaccinesSai T Reddy, André J van der Vlies, Eleonora Simeoni, et al.
Plos One|June 2, 2018
Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapyPetr O Ilyinskii, Grigoriy I Kovalev, Conlin P O'Neil, et al.
JCI Insight|May 18, 2018
TLR-adjuvanted nanoparticle vaccines differentially influence the quality and longevity of responses to malaria antigen Pfs25Elizabeth A Thompson, Sebastian Ols, Kazutoyo Miura, et al.
Vaccine|March 6, 2014
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine releasePetr O Ilyinskii, Christopher J Roy, Conlin P O'Neil, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Biomaterials|December 25, 2010
Engineering complement activation on polypropylene sulfide vaccine nanoparticlesSusan N Thomas, André J van der Vlies, Conlin P O'Neil, et al.
Angewandte Chemie (International Ed. in English)|September 16, 2008
Superparamagnetic nanoparticles as a powerful systems biology characterization tool in the physiological contextJatuporn Salaklang, Benedikt Steitz, Andrija Finka, et al.
Nature Biotechnology|September 18, 2007
Exploiting lymphatic transport and complement activation in nanoparticle vaccinesSai T Reddy, André J van der Vlies, Eleonora Simeoni, et al.
Plos One|June 2, 2018
Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapyPetr O Ilyinskii, Grigoriy I Kovalev, Conlin P O'Neil, et al.
JCI Insight|May 18, 2018
TLR-adjuvanted nanoparticle vaccines differentially influence the quality and longevity of responses to malaria antigen Pfs25Elizabeth A Thompson, Sebastian Ols, Kazutoyo Miura, et al.
Vaccine|March 6, 2014
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine releasePetr O Ilyinskii, Christopher J Roy, Conlin P O'Neil, et al.
Pageof 2